---
title: "雲南貝泰妮生物科技集團股份有限公司 (300957.SZ)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/300957.SZ.md"
symbol: "300957.SZ"
name: "雲南貝泰妮生物科技集團股份有限公司"
industry: "個人護理產品"
---

# 雲南貝泰妮生物科技集團股份有限公司 (300957.SZ)

| Item | Detail |
|------|--------|
| Industry | 個人護理產品 |
| Location | 滬深市場 |
| Website | [www.botanee.com.cn](https://www.botanee.com.cn) |

## Company Profile

公司成立于 2010 年，是一家集研發、生產和營銷為一體，定位于皮膚健康互聯網 + 的大健康產業集團。致力于打造中國皮膚健康生態，推動中國皮膚大健康事業的發展。公司于 2021 年 3 月 25 日登陸深交所創業板。公司主要從事化妝品研發、生產及銷售業務。公司的主要產品主要包括面霜、護膚水、面膜、精華以及乳液等護膚品類產品和隔離霜、粉餅、BB 霜以及卸妝水等彩妝類產品、透明質酸修護生物膜、透明質酸修護貼敷料等專業用于微創術后屏障受損皮膚的保護和護理的醫療器械以及家用電子射頻美容儀產品等。企業榮譽：雲南省功效性護膚品工程研究中心、雲南省專精特新 “小巨人”、雲南省五一勞動獎狀等。先后榮獲國家綠色...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:09.000Z

**Overall: C (0.44)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 15 / 27 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -17.92% |  |
| Net Profit YoY | -39.20% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 3.26 |  |
| Dividend Ratio | 1.28% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 19.82B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 5.18B |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.01% | C |
| Profit Margin | 6.95% | B |
| Gross Margin | 68.50% | A |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -17.92% | E |
| Net Profit YoY | -39.20% | D |
| Total Assets YoY | 5.09% | C |
| Net Assets YoY | 2.88% | C |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 1438.90% | B |
| OCF YoY | -17.92% | E |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.65 | B |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 24.15% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 雲南貝泰妮生物科技集團股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.01%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "6.95%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "68.50%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-17.92%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-39.20%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "5.09%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "2.88%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "1438.90%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-17.92%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.65",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "24.15%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 珀萊雅 (SH.603605) | A | C | A | B | C | B |
| 02 | 飛科電器 (SH.603868) | B | D | A | A | C | B |
| 03 | 丸美生物 (SH.603983) | B | B | B | B | B | B |
| 04 | 天新藥業 (SH.603235) | B | B | C | A | C | B |
| 05 | 潤本股份 (SH.603193) | A | B | B | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 55.04 | 15/28 | 57.37 | 52.44 | 47.41 |
| PB | 3.26 | 14/28 | 3.26 | 3.10 | 2.92 |
| PS (TTM) | 3.83 | 17/28 | 3.66 | 3.41 | 3.24 |
| Dividend Yield | 1.27% | 13/28 | 1.44% | 1.35% | 1.30% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-10T16:00:00.000Z

Total Analysts: **13**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 31% |
| Overweight | 1 | 8% |
| Hold | 7 | 54% |
| Underweight | 0 | 0% |
| Sell | 1 | 8% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 46.80 |
| Highest Target | 66.00 |
| Lowest Target | 36.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/300957.SZ/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/300957.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/300957.SZ/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.